Praxis Medical Insights

Est. 2024 • Clinical Guidelines Distilled

Made possible by volunteer editors from the University of Calgary & University of Alberta

Last Updated: 11/7/2025

Risk of Fibroadenoma Converting to Malignancy

Clinical Classification and Risk Stratification

  • The National Comprehensive Cancer Network guidelines classify stable fibroadenomas unchanged on successive ultrasound studies as BI-RADS Category 2 (Benign Finding), essentially negative for malignancy, with a classification based on imaging characteristics and associated cancer risk 1, 2
  • Fibroadenomas with circumscribed margins, oval shape, and horizontal orientation have less than 2% risk for malignancy and are classified as BI-RADS Category 3 (Probably Benign) 1, 2

Important Distinction: Phyllodes Tumors

  • Phyllodes tumors often appear identical to fibroadenomas on ultrasound and mammography, making preoperative distinction difficult 3
  • In the setting of a large (>2 cm) or rapidly enlarging clinical "fibroadenoma," excisional biopsy should be performed to pathologically exclude phyllodes tumor 3

Management Implications

  • The American College of Radiology recommends excision for fibroadenomas larger than 2 cm in size and for patient request or anxiety about the mass 4

REFERENCES

1

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

2

nccn clinical practice guidelines in oncology: breast cancer screening and diagnosis. [LINK]

Journal of the National Comprehensive Cancer Network : JNCCN, 2009

3

Diagnostic Criteria and Treatment of Phyllodes Tumors [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025

4

Management of Fibroadenomas [LINK]

Praxis Medical Insights: Practical Summaries of Clinical Guidelines, 2025